Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $1,328 | 1 | 65.7% |
| Food and Beverage | $471.99 | 29 | 23.4% |
| Consulting Fee | $125.00 | 1 | 6.2% |
| Education | $95.51 | 1 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $1,365 | 3 | $0 (2023) |
| Shire North American Group Inc | $233.41 | 8 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $130.75 | 3 | $0 (2020) |
| OPKO Pharmaceuticals, LLC | $63.52 | 4 | $0 (2018) |
| Relypsa, Inc. | $56.36 | 4 | $0 (2018) |
| Amgen Inc. | $51.72 | 3 | $0 (2018) |
| Keryx Biopharmaceuticals, Inc. | $39.42 | 2 | $0 (2018) |
| Mallinckrodt LLC | $23.51 | 2 | $0 (2018) |
| Mallinckrodt Hospital Products Inc. | $20.91 | 1 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $18.81 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $42.46 | 2 | Horizon Therapeutics plc ($21.55) |
| 2020 | $1,423 | 2 | Horizon Therapeutics plc ($1,328) |
| 2019 | $34.35 | 2 | Otsuka America Pharmaceutical, Inc. ($18.76) |
| 2018 | $233.42 | 15 | OPKO Pharmaceuticals, LLC ($63.52) |
| 2017 | $286.76 | 11 | Shire North American Group Inc ($172.12) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/01/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: KRYSTEXXA | ||||||
| 07/10/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2020 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $1,327.50 | General |
| Category: KRYSTEXXA | ||||||
| 01/17/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $95.51 | General |
| Category: NEPHROLOGY | ||||||
| 12/13/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: KRYSTEXXA | ||||||
| 04/05/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: NEPHROLOGY | ||||||
| 11/16/2018 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Hyperparathyroidism | ||||||
| 10/19/2018 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/05/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Nephrology | ||||||
| 09/21/2018 | Keryx Biopharmaceuticals, Inc. | Auryxia (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Nephrology | ||||||
| 09/07/2018 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/10/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: NEPHROLOGY | ||||||
| 06/29/2018 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Hyperparathyroidism | ||||||
| 05/18/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 05/18/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Hyperkalemia | ||||||
| 05/04/2018 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/02/2018 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Nephrology | ||||||
| 03/23/2018 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Hyperparathyroidism | ||||||
| 03/08/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: Hyperkalemia | ||||||
| 02/09/2018 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Hyperparathyroidism | ||||||
| 01/19/2018 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/01/2017 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/16/2017 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/17/2017 | Shire North American Group Inc | NATPARA (Drug) | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/06/2017 | Shire North American Group Inc | NATPARA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 877 | 2,044 | $323,666 | $188,944 |
| 2022 | 8 | 710 | 1,676 | $284,051 | $182,765 |
| 2021 | 8 | 877 | 2,292 | $373,759 | $250,555 |
| 2020 | 9 | 1,032 | 2,582 | $439,255 | $278,630 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 82 | 297 | $111,375 | $81,390 | 73.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 154 | 657 | $64,386 | $40,251 | 62.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 351 | $47,385 | $24,022 | 50.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 84 | $12,012 | $7,911 | 65.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 48 | $13,728 | $6,227 | 45.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 19 | 23 | $7,245 | $5,283 | 72.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 50 | 159 | $12,720 | $4,886 | 38.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $8,140 | $4,399 | 54.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 51 | 93 | $9,300 | $3,486 | 37.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 32 | 81 | $8,100 | $2,966 | 36.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 32 | 66 | $9,900 | $2,925 | 29.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 41 | 67 | $13,400 | $2,486 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 35 | $4,025 | $2,147 | 53.4% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 39 | 39 | $1,950 | $565.50 | 29.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 89 | 287 | $107,279 | $81,233 | 75.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 206 | 782 | $75,844 | $44,033 | 58.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 193 | 331 | $44,594 | $25,474 | 57.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 63 | 63 | $17,931 | $9,569 | 53.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 63 | 107 | $15,100 | $8,614 | 57.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 26 | 34 | $10,630 | $8,037 | 75.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $9,229 | $3,921 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 34 | $3,445 | $1,885 | 54.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 102 | 361 | $127,275 | $99,684 | 78.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 251 | 1,119 | $109,662 | $63,728 | 58.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 207 | 376 | $49,410 | $35,303 | 71.4% |
About Dr. Rizwan Khan, D.O
Dr. Rizwan Khan, D.O is a Internal Medicine healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2010. The National Provider Identifier (NPI) number assigned to this provider is 1407169477.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rizwan Khan, D.O has received a total of $2,020 in payments from pharmaceutical and medical device companies, with $42.46 received in 2023. These payments were reported across 32 transactions from 11 companies. The most common payment nature is "Honoraria" ($1,328).
As a Medicare-enrolled provider, Khan has provided services to 3,496 Medicare beneficiaries, totaling 8,594 services with total Medicare billing of $900,895. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Clermont, FL
- Active Since 07/20/2010
- Last Updated 09/17/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407169477
Products in Payments
- KRYSTEXXA (Biological) $1,365
- NATPARA (Drug) $233.41
- JYNARQUE (Drug) $95.51
- Rayaldee (Drug) $63.52
- Veltassa (Drug) $56.36
- ACTHAR (Biological) $44.42
- Auryxia (Drug) $39.42
- SAMSCA (Drug) $35.24
- Parsabiv (Biological) $33.38
- Velphoro (Drug) $18.81
- Sensipar (Drug) $18.34
- KRYSTEXXA (Drug) $16.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clermont
Sumith Aleti, Md, MD
Internal Medicine — Payments: $29,143
Alexander Bolanos, M.d, M.D
Internal Medicine — Payments: $15,769
Nathan Bibliowicz, Do, DO
Internal Medicine — Payments: $14,320
Dr. Shazia Nasir, Md, MD
Internal Medicine — Payments: $11,207
Carolina Mejia Otero, M.d, M.D
Internal Medicine — Payments: $7,926
Dr. Kiran Mogali, M.d, M.D
Internal Medicine — Payments: $7,620